Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06305910
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-03-05
Brief Title:
CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMGDIPG in Children and Young Adults
Sponsor:
OX2 Therapeutics
Organization:
OX2 Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-09-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-05
First Submit QC Date:
March 5 2024
Study First Post Date:
2024-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-05
Last Update Post Date:
2024-03-12
Last Update Post Date Type:
ACTUAL